Drug development

French and Belgian researchers have genetically modified strains of the bacteria as treatments for human gastrointestinal disorderse – and are keen to form licensing and partnering deals to take this research forward.

The European Union's plan to transform Europe's drug discovery industry borrows some of its style from the US - but not everything.